Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Rob Van Marum"'
Autor:
Alireza Malek Makan, Hein van Hout, Graziano Onder, Harriet Finne-Soveri, Daniela Fialova, Rob van Marum
Publikováno v:
BMC Geriatrics, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Objective The aim of this study was to determine the prevalence of potentially inappropriate medications (PIMs) in nursing home residents across eight countries and investigate differences between residents with and without cognitive impairm
Externí odkaz:
https://doaj.org/article/1d7cd7b12c49465da6c39b7982d374a9
Autor:
Hanneke Stam, Thomas Harting, Marjolijn van der Sluijs, Rob van Marum, Henriëtte van der Horst, Johannes C. van der Wouden, Otto R. Maarsingh
Publikováno v:
Scandinavian Journal of Primary Health Care, Vol 34, Iss 2, Pp 165-171 (2016)
Objective: For general practitioners (GPs) dizziness is a challenging condition to deal with. Data on the management of dizziness in older patients are mostly lacking. Furthermore, it is unknown whether GPs attempt to decrease Fall Risk Increasing Dr
Externí odkaz:
https://doaj.org/article/247d31e9f85446f7a8cc46b98fdfb1c7
Autor:
Jamila Abou, Stijn Crutzen, Vashti Tromp, Mette Heringa, Rob Van Marum, Petra Elders, Katja Taxis, Petra Denig, Jacqueline Hugtenburg
Publikováno v:
Drugs & Aging, 39(3), 209-221. ADIS INT LTD
Abou, J, Crutzen, S, Tromp, V, Heringa, M, van Marum, R, Elders, P, Taxis, K, Denig, P & Hugtenburg, J 2022, ' Barriers and Enablers of Healthcare Providers to Deprescribe Cardiometabolic Medication in Older Patients : A Focus Group Study ', Drugs and Aging, vol. 39, no. 3, pp. 209-221 . https://doi.org/10.1007/s40266-021-00918-7
Drugs and Aging, 39(3), 209-221. Adis International Ltd
Abou, J, Crutzen, S, Tromp, V, Heringa, M, van Marum, R, Elders, P, Taxis, K, Denig, P & Hugtenburg, J 2022, ' Barriers and Enablers of Healthcare Providers to Deprescribe Cardiometabolic Medication in Older Patients : A Focus Group Study ', Drugs and Aging, vol. 39, no. 3, pp. 209-221 . https://doi.org/10.1007/s40266-021-00918-7
Drugs and Aging, 39(3), 209-221. Adis International Ltd
INTRODUCTION: Benefits and risks of preventive medication change over time for ageing patients and deprescribing of medication may be needed. Deprescribing of cardiovascular and antidiabetic drugs can be challenging and is not widely implemented in d
Autor:
Silvia Ingala, Ingrid S. van Maurik, Daniele Altomare, Raphael Wurm, Ellen Dicks, Ronald A. van Schijndel, Marissa Zwan, Femke Bouwman, Niki Schoonenboom, Leo Boelaarts, Gerwin Roks, Rob van Marum, Barbera van Harten, Inge van Uden, Jules Claus, Viktor Wottschel, Hugo Vrenken, Mike P. Wattjes, Wiesje M. van der Flier, Frederik Barkhof
Publikováno v:
Ingala, S, van Maurik, I S, Altomare, D, Wurm, R, Dicks, E, van Schijndel, R A, Zwan, M, Bouwman, F, Schoonenboom, N, Boelaarts, L, Roks, G, van Marum, R, van Harten, B, van Uden, I, Claus, J, Wottschel, V, Vrenken, H, Wattjes, M P, van der Flier, W M & Barkhof, F 2022, ' Clinical applicability of quantitative atrophy measures on MRI in patients suspected of Alzheimer's disease ', European Radiology, vol. 32, no. 11, pp. 7789-7799 . https://doi.org/10.1007/s00330-021-08503-7, https://doi.org/10.1007/s00330-021-08503-7
European Radiology. Springer Verlag
European Radiology, 32(11), 7789-7799. Springer Verlag
European Radiology. Springer Verlag
European Radiology, 32(11), 7789-7799. Springer Verlag
Objectives Neurodegeneration in suspected Alzheimer’s disease can be determined using visual rating or quantitative volumetric assessments. We examined the feasibility of volumetric measurements of gray matter (GMV) and hippocampal volume (HCV) and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09784f91f3a8e59f993384acab5fe04e
https://research.vumc.nl/en/publications/b715f381-d382-4f51-8157-e938f03095f8
https://research.vumc.nl/en/publications/b715f381-d382-4f51-8157-e938f03095f8
Autor:
Tim Poel, Nikki de Rouw, Nathalie Péquériaux, Daan Van de Kerkhof, Annemieke Vermeulen Windsant, Rob van Marum, Angèle Kerckhoffs
Apixaban is a factor Xa inhibitor and is used in patients undergoing haemodialysis treatment. Apixaban can be cleared by haemodialysis, which might lead to decreased apixaban plasma concentrations and insufficient anticoagulation during and after hae
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6fe95fefd205889d4c93692464c8e05a
https://doi.org/10.22541/au.164873558.88065474/v1
https://doi.org/10.22541/au.164873558.88065474/v1
Autor:
Tinka Bakker, Joanna E. Klopotowska, Nicolette F. de Keizer, Rob van Marum, Heleen van der Sijs, Dylan W. de Lange, Evert de Jonge, Ameen Abu-Hanna, Dave A. Dongelmans, S. Hendriks, J. ten Cate, D. van Balen, M. Duyvendak, A. Karakus, M. Sigtermans, E.M. Kuck, N.G.M. Hunfeld, P.E. Spronk, H.J.M. van Kan, M.S. van der Steen, B.E. Bosma, I. Purmer, H. Kieft, A. Beishuizen, K. Movig, J.W. Vermeijden, F. Mulder, R.J. Bosman, E.J.F. Franssen, E.J. Wils, P.W. de Feiter, W.M. van den Bergh, W. Bult, M. Hoeksema, E. Wesselink
Publikováno v:
Journal of Critical Care, 57, 134. Elsevier BV
Journal of Critical Care, 57, 134-140. Elsevier
Journal of critical care, 57, 134-140. Elsevier BV
Bakker, T, Klopotowska, J E, de Keizer, N F, van Marum, R, van der Sijs, H, de Lange, D W, de Jonge, E, Abu-Hanna, A & Dongelmans, D A 2020, ' Improving medication safety in the Intensive Care by identifying relevant drug-drug interactions-Results of a multicenter Delphi study ', Journal of Critical Care, vol. 57, pp. 134-140 . https://doi.org/10.1016/j.jcrc.2020.02.012
Journal of Critical Care, 57, 134-140. W B SAUNDERS CO-ELSEVIER INC
Journal of Critical Care, 57, 134-140. Elsevier BV
Journal of Critical Care, 57, 134-140. Elsevier
Journal of critical care, 57, 134-140. Elsevier BV
Bakker, T, Klopotowska, J E, de Keizer, N F, van Marum, R, van der Sijs, H, de Lange, D W, de Jonge, E, Abu-Hanna, A & Dongelmans, D A 2020, ' Improving medication safety in the Intensive Care by identifying relevant drug-drug interactions-Results of a multicenter Delphi study ', Journal of Critical Care, vol. 57, pp. 134-140 . https://doi.org/10.1016/j.jcrc.2020.02.012
Journal of Critical Care, 57, 134-140. W B SAUNDERS CO-ELSEVIER INC
Journal of Critical Care, 57, 134-140. Elsevier BV
Purpose: Drug-drug interactions (DDIs) may cause adverse outcomes in patients admitted to the Intensive Care Unit (ICU). Computerized decision support systems (CDSSs) may help prevent DDIs by timely showing relevant warning alerts, but knowledge on w
Autor:
Rob van Marum
Publikováno v:
De dokter en de dood ISBN: 9789036820592
De dokter en de dood
De dokter en de dood
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::18855654e0ba2c5a89f8e53091a00106
https://doi.org/10.1007/978-90-368-2060-8_22
https://doi.org/10.1007/978-90-368-2060-8_22
Publikováno v:
Clinical Research and Regulatory Affairs. 20:341-348
Background. In pharmacology the clinical efficacy of a compound is generally strongly dependent on baseline characteristics of the test subjects. In recent HMG -CoA reductase inhibitor (statin) studies this was not so. However, these studies used sub
Autor:
Edeltraut, Kröger, Rob, Van Marum, Patrick, Souverein, Pierre-Hugues, Carmichael, Toine, Egberts
Publikováno v:
Pharmacoepidemiology and drug safety. 24(3)
Treatment of Alzheimer disease (AD) with cholinesterase inhibitors (ChEIs) may increase the risk of urinary incontinence (UI).To assess whether ChEI use was associated with the risk of UI among older patients with AD.A crossover cohort study using th
Autor:
Rob van Marum, Ton J. Cleophas
Publikováno v:
The American Journal of Cardiology. 87:487-490
Second-generation dihydropyridine calcium channel blockers slightly increase cardiac index, left ventricular ejection fraction, and exercise treadmill tests in patients with chronic heart failure, and do not increase norepinephrine levels; these drug